Bryan V. Lawlis, a director at Geron Corp ($GERN), made one open market purchase of shares in the last year, totaling about $15,667, with the most recent on May 9, 2025. This ranks 4,007th among 4,983 insiders in our database, where the average buy is $1.46 million across about 3.3 transactions. Lawlis reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 21, 2025 | GERON CORP | $GERN | LAWLIS V BRYAN | Director | A | Stock Option (right to buy) | 180000 | $0.00 | 180,000.0000 | 646,033,247 | 9999.99% | 0.03% |
| May 9, 2025 | GERON CORP | $GERN | LAWLIS V BRYAN | Director | P | Common Stock | 13300 | $1.18 | 13,300.0000 | 646,033,247 | 9999.99% | 0.00% |
| May 15, 2024 | GERON CORP | $GERN | LAWLIS V BRYAN | Not found | S | Common Stock | 35000 | $3.75 | 0.0000 | 570,645,405 | 100.00% | 0.01% |
| May 15, 2024 | GERON CORP | $GERN | LAWLIS V BRYAN | Not found | M | Stock Option (right to buy) | 35000 | $0.00 | 0.0000 | 570,645,405 | 100.00% | 0.01% |
| May 15, 2024 | GERON CORP | $GERN | LAWLIS V BRYAN | Not found | M | Common Stock | 35000 | $1.94 | 35,000.0000 | 570,645,405 | 9999.99% | 0.01% |
| May 9, 2024 | GERON CORP | $GERN | LAWLIS V BRYAN | Not found | A | Stock Option (right to buy) | 180000 | $0.00 | 180,000.0000 | 570,645,405 | 9999.99% | 0.03% |
| May 31, 2023 | GERON CORP | $GERN | LAWLIS V BRYAN | Director | A | Stock Option (right to buy) | 125000 | $0.00 | 125,000.0000 | 380,784,846 | 9999.99% | 0.03% |
| May 23, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | LAWLIS V BRYAN | Director | A | Common Stock | 4190 | $0.00 | 33,140.0000 | 188,963,000 | 14.47% | 0.00% |
| May 11, 2023 | GERON CORP | $GERN | LAWLIS V BRYAN | Director | M | Common Stock | 35000 | $1.10 | 35,000.0000 | 380,784,846 | 9999.99% | 0.01% |
| May 11, 2023 | GERON CORP | $GERN | LAWLIS V BRYAN | Director | S | Common Stock | 35000 | $3.00 | 0.0000 | 380,784,846 | 100.00% | 0.01% |
| May 11, 2023 | GERON CORP | $GERN | LAWLIS V BRYAN | Director | M | Stock Options (right to buy) | 35000 | $0.00 | 0.0000 | 380,784,846 | 100.00% | 0.01% |
| April 3, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | LAWLIS V BRYAN | Director | M | Common Stock | 8500 | $67.81 | 37,450.0000 | 188,963,000 | 29.36% | 0.00% |
| April 3, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | LAWLIS V BRYAN | Director | S | Common Stock | 8500 | $97.09 | 28,950.0000 | 188,963,000 | 22.70% | 0.00% |
| April 3, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | LAWLIS V BRYAN | Director | M | Stock Option (Right to Buy Common Stock) | 8500 | $0.00 | 0.0000 | 188,963,000 | 100.00% | 0.00% |